BARAZZONI, ROCCO
 Distribuzione geografica
Continente #
NA - Nord America 16.148
EU - Europa 10.811
AS - Asia 7.534
SA - Sud America 2.008
AF - Africa 198
OC - Oceania 123
Continente sconosciuto - Info sul continente non disponibili 25
Totale 36.847
Nazione #
US - Stati Uniti d'America 15.348
CN - Cina 2.552
IT - Italia 2.416
PL - Polonia 2.215
SG - Singapore 1.340
BR - Brasile 1.242
SE - Svezia 1.023
HK - Hong Kong 844
UA - Ucraina 826
JP - Giappone 740
ES - Italia 680
TR - Turchia 680
DE - Germania 652
MX - Messico 621
RU - Federazione Russa 381
FI - Finlandia 328
ID - Indonesia 320
GB - Regno Unito 286
IE - Irlanda 242
BG - Bulgaria 231
FR - Francia 222
IN - India 215
AR - Argentina 208
CO - Colombia 207
NL - Olanda 206
CH - Svizzera 202
PT - Portogallo 169
GR - Grecia 157
VN - Vietnam 142
TW - Taiwan 134
BE - Belgio 128
CA - Canada 113
CL - Cile 109
AU - Australia 105
IL - Israele 100
KR - Corea 94
PE - Perù 92
TH - Thailandia 80
AT - Austria 79
EC - Ecuador 72
DK - Danimarca 54
MY - Malesia 51
SI - Slovenia 51
EG - Egitto 47
PH - Filippine 42
RO - Romania 42
NO - Norvegia 41
HU - Ungheria 38
IR - Iran 38
VE - Venezuela 35
SA - Arabia Saudita 33
CZ - Repubblica Ceca 26
SN - Senegal 26
TN - Tunisia 23
CR - Costa Rica 20
HR - Croazia 20
PK - Pakistan 20
ZA - Sudafrica 20
NZ - Nuova Zelanda 18
LT - Lituania 17
AE - Emirati Arabi Uniti 16
EU - Europa 16
PY - Paraguay 16
RS - Serbia 16
BD - Bangladesh 15
BO - Bolivia 15
LV - Lettonia 15
NG - Nigeria 13
MA - Marocco 12
SK - Slovacchia (Repubblica Slovacca) 12
UY - Uruguay 10
DZ - Algeria 9
ET - Etiopia 9
MD - Moldavia 9
PA - Panama 9
A2 - ???statistics.table.value.countryCode.A2??? 8
EE - Estonia 8
HN - Honduras 8
NP - Nepal 8
CY - Cipro 7
LK - Sri Lanka 7
PR - Porto Rico 7
AL - Albania 6
IS - Islanda 6
LB - Libano 6
KZ - Kazakistan 5
SV - El Salvador 5
ZM - Zambia 5
AF - Afghanistan, Repubblica islamica di 4
AZ - Azerbaigian 4
BB - Barbados 4
BY - Bielorussia 4
GT - Guatemala 4
LA - Repubblica Popolare Democratica del Laos 4
MM - Myanmar 4
SD - Sudan 4
TZ - Tanzania 4
UZ - Uzbekistan 4
BF - Burkina Faso 3
CD - Congo 3
Totale 36.787
Città #
Warsaw 2.050
Woodbridge 1.971
Fairfield 1.759
Houston 1.386
Ann Arbor 1.342
Ashburn 1.015
Chandler 1.004
Wilmington 843
Hong Kong 805
Jacksonville 776
Seattle 767
Singapore 704
Cambridge 584
Trieste 526
Boardman 407
Princeton 346
Beijing 293
Izmir 249
Columbus 245
Sofia 227
Dublin 224
Madrid 197
São Paulo 194
Milan 193
Rome 174
Shanghai 173
Moscow 170
Tokyo 150
Istanbul 133
Dearborn 114
Guangzhou 108
Bern 105
Rio de Janeiro 102
Ankara 101
Bogotá 98
San Diego 96
Santa Clara 90
Redmond 87
Buenos Aires 85
Barcelona 82
Los Angeles 78
Athens 76
Jakarta 72
Chengdu 70
Lisbon 67
Nanjing 67
Santiago 67
Brussels 64
Chicago 63
Grafing 63
Hangzhou 62
Lima 54
Salvador 54
Naples 53
Amsterdam 52
Medellín 52
Nuremberg 52
Valencia 52
Belo Horizonte 51
Brasília 51
Mexico City 51
Bangkok 50
Chongqing 49
Helsinki 49
Hanoi 47
Tel Aviv 47
Jinan 46
Falls Church 45
Frankfurt am Main 44
Xi'an 44
Hefei 43
Taipei 43
Verona 43
Bologna 42
Florence 42
Vienna 42
Guadalajara 40
Ho Chi Minh City 40
Turin 40
Porto 39
Porto Alegre 38
Shenyang 38
Des Moines 37
Curitiba 36
Munich 36
Quito 36
Ljubljana 35
Dong Ket 34
Paris 34
Sydney 34
Wuhan 34
Dallas 33
Osaka 33
Phoenix 33
Fortaleza 32
Krakow 32
Pune 31
Toronto 31
Kunming 30
Mumbai 30
Totale 22.758
Nome #
ESPEN guidelines on definitions and terminology of clinical nutrition 3.067
GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community 2.745
Could ketogenic diet "starve" cancer? Emerging evidence 1.149
Nutritional status and the risk of malnutrition in older adults with chronic kidney disease – implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN 1.061
Diagnostic criteria for malnutrition - An ESPEN Consensus Statement 925
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition (GLIM) diagnosis of malnutrition 681
Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review 411
Tuberculosis and malnutrition: The European perspective 410
AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia 408
Unacylated ghrelin reduces skeletal muscle reactive oxygen species generation and inflammation and prevents high-fat diet-induced hyperglycemia and whole-body insulin resistance in rodents 398
GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community 385
Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall 343
Update on the impact of omega 3 fatty acids on inflammation, insulin resistance and sarcopenia: A review 330
Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo 327
Lack of Fibronectin Extra Domain A Alternative Splicing Exacerbates Endothelial Dysfunction in Diabetes 314
Omega 3 Polyunsaturated Fatty Acids Improve Endothelial Dysfunction in Chronic Renal Failure: Role of eNOS Activation and of Oxidative Stress 295
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure 285
Nutritional status and physical inactivity in moderated asthmatics: A pilot study 283
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) – Proceedings from the SOGLI consortium meeting in Rome November 2022 265
Poor nutritional status but not cognitive or functional impairment per se independently predict 1 year mortality in elderly patients with hip-fracture 256
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction 253
Towards a multidisciplinary approach to understand and manage obesity and related diseases 251
Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals 239
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition diagnosis of malnutrition 230
Sarcopenic Obesity: Time to Meet the Challenge 230
Unacylated ghrelin improves vascular dysfunction and attenuates atherosclerosis during high-fat diet consumption in rodents 225
Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome. 217
Nutrition in Renal Disease 214
Acylated Ghrelin Limits Fat Accumulation and Improves Redox State and Inflammation Markers in the Liver of High-Fat-Fed Rats. 207
Decreased VLDL-Apo B 100 fractional synthesis rate despite hypertriglyceridemia in subjects with type 2 diabetes and nephropathy 207
High-fat diet with acyl-ghrelin treatment leads to weight gain with low inflammation, high oxidative capacity and normal triglycerides in rat muscle. 204
Insulin resistance in obesity: an overview of fundamental alterations 203
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 194
Exposure to artificial light at night: A common link for obesity and cancer? 193
Treatment with n-3 Polyunsaturated Fatty Acids Reverses Endothelial Dysfunction and Oxidative Stress in Experimental Menopause 185
Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease 184
Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group 183
Nutrition education in medical schools (NEMS). An ESPEN position paper 181
Sarcopenic obesity: What about in the cancer setting? 176
A negative impact of recent weight loss on in-hospital mortality is not modified by overweight and obesity 176
Effectiveness and efficacy of nutritional therapy: a systematic review following Cochrane methodology 164
Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers 162
Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction. 159
Standard operating procedures for ESPEN guidelines and consensus papers 156
null 155
Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group 155
null 152
Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance 151
Ghrelin forms in the modulation of energy balance and metabolism 149
Fighting protein-energy wasting in chronic kidney disease: a challenge of complexity. 145
Acute Infusion of N-3 Polyunsaturated (N-3 PUFA) Fatty Acids is not Associated with Enhanced Reactive Oxygen Species Generation and Lowers Mitochondrial ATP Production in Rat Liver 142
The role of substrates in the regulation of protein metabolism. 141
Hyperglucagonemia stimulates phenylalanine oxidation in humans. 141
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations. 139
Protein degradation and synthesis measured with multiple amino acid tracers in vivo. 139
A model of skeletal muscle leucine kinetics measured across the human forearm. 138
null 138
Evidence for acute stimulation of fibrinogen production by glucagon in humans 137
Time-dependent changes in plasma total, acylated and desacylated ghrelin after gastric by-pass 136
Sarcopenic obesity: Time to meet the challenge 136
null 135
Spot-light on microbiota in obesity and cancer 134
null 134
null 134
Protein metabolism in glucagonoma. 133
null 132
Effects of branched-chain-enriched amino acids and insulin on forearm leucine kinetics. 132
Clinical nutrition university: Muscle physiology and bioenergetics 132
n-3-Pufa Dietary Enrichment Improves Whole-Body Insulin Action and Normalizes Muscle Mass, Mitochondrial Function, Oxidative Stress, and Insulin Signalling in Experimental Uremia 130
null 128
Perioperative nutritional support. 127
Response of phenylalanine and leucine kinetics to branched chain-enriched amino acids and insulin in patients with cirrhosis. 125
null 125
null 123
Differential Cross-Sectional and Prospective Predictive Value for Insulin Resistance of Different Anthropometric Indexes and Parameters in A North-East Italy Community-Based Population Cohort 122
n-3 PUFA dietary lipid replacement normalizes muscle mitochondrial function and oxidative stress through enhanced tissue mitophagy and protects from muscle wasting in experimental kidney disease 121
null 121
null 121
null 121
Differences in estimates of forearm protein synthesis between leucine and phenylalanine tracers following unbalanced amino acid infusion. 121
null 119
null 119
Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis 119
Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile 118
null 118
null 118
Effect of insulin sensitizer therapy on amino acids and their metabolites 117
Unacylated Ghrelin Normalizes Oxidative Stress and Insulin Action in Rat Muscle and Prevents Muscle Loss in Experimental Uremia 117
Obesity: focus on ongoing multidisciplinary and comprehensive research 117
Mechanisms of postprandial protein accretion in human skeletal muscle. Insight from leucine and phenylalanine forearm kinetics. 116
null 115
Splanchnic amino acid and protein turnover in humans: insight from isotope dilution and catheterization studies. 114
null 114
Protein metabolism in Type 1 and Type 2 diabetes mellitus in the fasted and fed states 114
null 113
null 113
null 113
null 112
null 112
null 111
Totale 26.285
Categoria #
all - tutte 95.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020919 0 0 0 0 0 0 0 0 0 246 363 310
2020/20213.297 334 194 260 342 331 325 195 383 185 346 121 281
2021/20222.208 75 169 143 167 68 219 93 93 256 250 197 478
2022/20233.136 278 335 223 446 276 554 56 229 357 43 276 63
2023/20244.137 242 159 157 125 169 238 344 396 17 228 974 1.088
2024/202512.912 1.019 1.083 1.371 1.534 1.640 1.409 1.518 1.313 1.977 48 0 0
Totale 37.797